βグルカン市場：製品タイプ、供給源、用途別-2025-2030年世界予測

βグルカン市場は、2023年に5億7,101万米ドルと評価され、2024年には6億1,675万米ドルに達すると予測され、CAGR 8.18%で成長し、2030年には9億9,045万米ドルに達すると予測されています。

βグルカンは、穀類、細菌、菌類の細胞壁に含まれる天然由来の多糖類であり、その重要な健康上の利点と様々な産業への応用が認められています。βグルカンの必要性は、その免疫増強作用とコレステロール低下作用に起因しており、栄養補助食品、医薬品、機能性食品に欠かせないものとなっています。さらに、その皮膚鎮静作用から化粧品にも応用されています。最終用途の範囲は広く、健康・ウェルネス、医薬品、飲食品、パーソナルケアなどの分野を包含します。市場の成長には、健康とウェルネスに対する消費者の意識の高まり、生活習慣病の有病率の増加、天然成分やオーガニック成分への需要が影響しています。しかし、特に新興国市場においては、高い製造コスト、特定地域における消費者の認識不足、厳しい規制承認といった課題に直面しています。とはいえ、予防ヘルスケアに向けた動向の高まりや研究開発活動の活発化は、潜在的なビジネスチャンスをもたらしています。抽出・加工技術の革新は、生産コストを下げ、製品の有効性を高め、用途を拡大することができるため、市場関係者に有利な機会を提供することができます。企業は、急成長する市場を活用するために、戦略的パートナーシップ、技術の進歩、製品の多様化に注力すべきです。認知度向上キャンペーンに取り組むことも、消費者の知識格差の解消に役立つと思われます。競合情勢は、その多様な応用可能性と健康上の利点により、市場成長軌道に乗る一方で、絶え間ないイノベーションと戦略的ポジショニングを要求しています。さらに、持続可能な慣行への投資と、未開拓のアジア市場への参入は、長期的な成長にとって極めて重要です。これらの分野に注力することで、企業は市場の限界を乗り越え、その拡大の可能性を活用することができます。

市場力学：急速に進化するβグルカン市場の主要市場インサイトを公開

βグルカン市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • βグルカンの健康効果に関する消費者の意識の高まり
  • 栄養補助食品と機能性食品に対する需要の高まり
• 市場抑制要因
  • βグルカンの生産に関連する原材料価格の変動
• 市場機会
  • βグルカンの新しい供給源、送達システムの開発のための研究開発の増加
  • 動物飼料および獣医学的応用における高い可能性
• 市場の課題
  • βグルカンの製剤化と安定性における問題点

ポーターのファイブフォース：βグルカン市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：βグルカン市場における外部からの影響の把握

外部マクロ環境要因は、βグルカン市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析βグルカン市場における競合情勢の把握

βグルカン市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックスβグルカン市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、βグルカン市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨βグルカン市場における成功への道筋を描く

βグルカン市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • βグルカンの健康上の利点に関する消費者の意識の高まり
    • 栄養補助食品と機能性食品の需要増加
  • 抑制要因
    • βグルカンの生産に関連する原材料の価格変動
  • 機会
    • βグルカンの新しいソースと配信システムの開発のための研究開発の強化
    • 動物飼料および獣医用途における高い可能性
  • 課題
    • βグルカンの定式化と安定性に関する特定の問題
• 市場セグメンテーション分析
  • 製品：肌を落ち着かせる特性により、パーソナルケアや化粧品におけるアベナケアの使用が増加しています。
  • 応用：抗生物質の使用を減らし、持続可能な動物衛生慣行を促進するための動物飼料におけるβグルカンの高い可能性
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 βグルカン市場：製品別

• アベナケア
• グルカゲル
• ニュートリム
• オートウェル
• プロモーション
• サナセル
• ウェルミューン
• イェスティムン

第7章 βグルカン市場：タイプ別

• 解決できないβグルカン
• 溶解可能なβグルカン

第8章 βグルカン市場：ソース別

• 穀物
• キノコ
• 海藻
• 酵母

第9章 βグルカン市場：用途別

• 動物飼料
• 化粧品・パーソナルケア
• 飲食品
• 医療・医薬品

第10章 南北アメリカのβグルカン市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋地域のβグルカン市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカのβグルカン市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
  • IFT食品博覧会でBENEOのOrafti B-Fitを発表：心臓に良い大麦ベータグルカンを紹介
• 戦略分析と提言

企業一覧

• ABF Ingredients Group
• Alltech Life Sciences
• Angel Yeast Co., Ltd.
• Associated British Foods PLC
• Auriga Group
• Biopolymer Engineering Inc.
• Biorigin
• Biotec Pharmacon ASA
• Cargill, Inc.
• Ceapro Inc.
• DSM Nutritional Products AG
• Euglena Co. Ltd
• Garuda International, Inc.
• Givaudan SA
• GlycaNova AS
• Kemin Industries Inc.
• Kerry Group PLC
• Merck KGaA
• NutraQ AS
• NutriScience Innovations, LLC
• Super Beta Glucan Inc.

LIST OF FIGURES

• FIGURE 1. BETA-GLUCAN MARKET RESEARCH PROCESS
• FIGURE 2. BETA-GLUCAN MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL BETA-GLUCAN MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL BETA-GLUCAN MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL BETA-GLUCAN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL BETA-GLUCAN MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL BETA-GLUCAN MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL BETA-GLUCAN MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL BETA-GLUCAN MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL BETA-GLUCAN MARKET SIZE, BY SOURCE, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL BETA-GLUCAN MARKET SIZE, BY SOURCE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL BETA-GLUCAN MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL BETA-GLUCAN MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. AMERICAS BETA-GLUCAN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. AMERICAS BETA-GLUCAN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. UNITED STATES BETA-GLUCAN MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 17. UNITED STATES BETA-GLUCAN MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. ASIA-PACIFIC BETA-GLUCAN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. ASIA-PACIFIC BETA-GLUCAN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA BETA-GLUCAN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. EUROPE, MIDDLE EAST & AFRICA BETA-GLUCAN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. BETA-GLUCAN MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 23. BETA-GLUCAN MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. BETA-GLUCAN MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL BETA-GLUCAN MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL BETA-GLUCAN MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL BETA-GLUCAN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. BETA-GLUCAN MARKET DYNAMICS
• TABLE 7. GLOBAL BETA-GLUCAN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL BETA-GLUCAN MARKET SIZE, BY AVENACARE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL BETA-GLUCAN MARKET SIZE, BY GLUCAGEL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL BETA-GLUCAN MARKET SIZE, BY NUTRIM, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL BETA-GLUCAN MARKET SIZE, BY OATWELL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL BETA-GLUCAN MARKET SIZE, BY PROMOAT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL BETA-GLUCAN MARKET SIZE, BY SANACEL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL BETA-GLUCAN MARKET SIZE, BY WELLMUNE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL BETA-GLUCAN MARKET SIZE, BY YESTIMUN, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL BETA-GLUCAN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL BETA-GLUCAN MARKET SIZE, BY INSOLUBLE BETA-GLUCAN, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL BETA-GLUCAN MARKET SIZE, BY SOLUBLE BETA-GLUCAN, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL BETA-GLUCAN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL BETA-GLUCAN MARKET SIZE, BY CEREAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL BETA-GLUCAN MARKET SIZE, BY MUSHROOM, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL BETA-GLUCAN MARKET SIZE, BY SEAWEED, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL BETA-GLUCAN MARKET SIZE, BY YEAST, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL BETA-GLUCAN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL BETA-GLUCAN MARKET SIZE, BY ANIMAL FEED, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL BETA-GLUCAN MARKET SIZE, BY COSMETICS & PERSONAL CARE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL BETA-GLUCAN MARKET SIZE, BY FOOD & BEVERAGE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL BETA-GLUCAN MARKET SIZE, BY MEDICAL & PHARMACEUTICALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 29. AMERICAS BETA-GLUCAN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 30. AMERICAS BETA-GLUCAN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 31. AMERICAS BETA-GLUCAN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 32. AMERICAS BETA-GLUCAN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 33. AMERICAS BETA-GLUCAN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 34. ARGENTINA BETA-GLUCAN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 35. ARGENTINA BETA-GLUCAN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 36. ARGENTINA BETA-GLUCAN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 37. ARGENTINA BETA-GLUCAN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 38. BRAZIL BETA-GLUCAN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 39. BRAZIL BETA-GLUCAN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 40. BRAZIL BETA-GLUCAN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 41. BRAZIL BETA-GLUCAN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 42. CANADA BETA-GLUCAN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 43. CANADA BETA-GLUCAN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 44. CANADA BETA-GLUCAN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 45. CANADA BETA-GLUCAN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 46. MEXICO BETA-GLUCAN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 47. MEXICO BETA-GLUCAN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 48. MEXICO BETA-GLUCAN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 49. MEXICO BETA-GLUCAN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 50. UNITED STATES BETA-GLUCAN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 51. UNITED STATES BETA-GLUCAN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 52. UNITED STATES BETA-GLUCAN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 53. UNITED STATES BETA-GLUCAN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 54. UNITED STATES BETA-GLUCAN MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 55. ASIA-PACIFIC BETA-GLUCAN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 56. ASIA-PACIFIC BETA-GLUCAN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 57. ASIA-PACIFIC BETA-GLUCAN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 58. ASIA-PACIFIC BETA-GLUCAN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 59. ASIA-PACIFIC BETA-GLUCAN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 60. AUSTRALIA BETA-GLUCAN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 61. AUSTRALIA BETA-GLUCAN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 62. AUSTRALIA BETA-GLUCAN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 63. AUSTRALIA BETA-GLUCAN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 64. CHINA BETA-GLUCAN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 65. CHINA BETA-GLUCAN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 66. CHINA BETA-GLUCAN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 67. CHINA BETA-GLUCAN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 68. INDIA BETA-GLUCAN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 69. INDIA BETA-GLUCAN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 70. INDIA BETA-GLUCAN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 71. INDIA BETA-GLUCAN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 72. INDONESIA BETA-GLUCAN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 73. INDONESIA BETA-GLUCAN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 74. INDONESIA BETA-GLUCAN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 75. INDONESIA BETA-GLUCAN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 76. JAPAN BETA-GLUCAN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 77. JAPAN BETA-GLUCAN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 78. JAPAN BETA-GLUCAN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 79. JAPAN BETA-GLUCAN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 80. MALAYSIA BETA-GLUCAN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 81. MALAYSIA BETA-GLUCAN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 82. MALAYSIA BETA-GLUCAN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 83. MALAYSIA BETA-GLUCAN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 84. PHILIPPINES BETA-GLUCAN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 85. PHILIPPINES BETA-GLUCAN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 86. PHILIPPINES BETA-GLUCAN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 87. PHILIPPINES BETA-GLUCAN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 88. SINGAPORE BETA-GLUCAN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 89. SINGAPORE BETA-GLUCAN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 90. SINGAPORE BETA-GLUCAN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 91. SINGAPORE BETA-GLUCAN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 92. SOUTH KOREA BETA-GLUCAN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 93. SOUTH KOREA BETA-GLUCAN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 94. SOUTH KOREA BETA-GLUCAN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 95. SOUTH KOREA BETA-GLUCAN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 96. TAIWAN BETA-GLUCAN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 97. TAIWAN BETA-GLUCAN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 98. TAIWAN BETA-GLUCAN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 99. TAIWAN BETA-GLUCAN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 100. THAILAND BETA-GLUCAN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 101. THAILAND BETA-GLUCAN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 102. THAILAND BETA-GLUCAN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 103. THAILAND BETA-GLUCAN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 104. VIETNAM BETA-GLUCAN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 105. VIETNAM BETA-GLUCAN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 106. VIETNAM BETA-GLUCAN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 107. VIETNAM BETA-GLUCAN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 108. EUROPE, MIDDLE EAST & AFRICA BETA-GLUCAN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 109. EUROPE, MIDDLE EAST & AFRICA BETA-GLUCAN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 110. EUROPE, MIDDLE EAST & AFRICA BETA-GLUCAN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 111. EUROPE, MIDDLE EAST & AFRICA BETA-GLUCAN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 112. EUROPE, MIDDLE EAST & AFRICA BETA-GLUCAN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 113. DENMARK BETA-GLUCAN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 114. DENMARK BETA-GLUCAN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 115. DENMARK BETA-GLUCAN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 116. DENMARK BETA-GLUCAN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 117. EGYPT BETA-GLUCAN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 118. EGYPT BETA-GLUCAN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 119. EGYPT BETA-GLUCAN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 120. EGYPT BETA-GLUCAN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 121. FINLAND BETA-GLUCAN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 122. FINLAND BETA-GLUCAN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 123. FINLAND BETA-GLUCAN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 124. FINLAND BETA-GLUCAN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 125. FRANCE BETA-GLUCAN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 126. FRANCE BETA-GLUCAN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 127. FRANCE BETA-GLUCAN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 128. FRANCE BETA-GLUCAN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 129. GERMANY BETA-GLUCAN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 130. GERMANY BETA-GLUCAN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 131. GERMANY BETA-GLUCAN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 132. GERMANY BETA-GLUCAN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 133. ISRAEL BETA-GLUCAN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 134. ISRAEL BETA-GLUCAN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 135. ISRAEL BETA-GLUCAN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 136. ISRAEL BETA-GLUCAN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 137. ITALY BETA-GLUCAN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 138. ITALY BETA-GLUCAN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 139. ITALY BETA-GLUCAN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 140. ITALY BETA-GLUCAN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 141. NETHERLANDS BETA-GLUCAN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 142. NETHERLANDS BETA-GLUCAN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 143. NETHERLANDS BETA-GLUCAN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 144. NETHERLANDS BETA-GLUCAN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 145. NIGERIA BETA-GLUCAN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 146. NIGERIA BETA-GLUCAN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 147. NIGERIA BETA-GLUCAN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 148. NIGERIA BETA-GLUCAN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 149. NORWAY BETA-GLUCAN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 150. NORWAY BETA-GLUCAN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 151. NORWAY BETA-GLUCAN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 152. NORWAY BETA-GLUCAN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 153. POLAND BETA-GLUCAN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 154. POLAND BETA-GLUCAN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 155. POLAND BETA-GLUCAN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 156. POLAND BETA-GLUCAN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 157. QATAR BETA-GLUCAN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 158. QATAR BETA-GLUCAN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 159. QATAR BETA-GLUCAN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 160. QATAR BETA-GLUCAN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 161. RUSSIA BETA-GLUCAN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 162. RUSSIA BETA-GLUCAN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 163. RUSSIA BETA-GLUCAN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 164. RUSSIA BETA-GLUCAN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 165. SAUDI ARABIA BETA-GLUCAN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 166. SAUDI ARABIA BETA-GLUCAN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 167. SAUDI ARABIA BETA-GLUCAN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 168. SAUDI ARABIA BETA-GLUCAN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 169. SOUTH AFRICA BETA-GLUCAN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 170. SOUTH AFRICA BETA-GLUCAN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 171. SOUTH AFRICA BETA-GLUCAN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 172. SOUTH AFRICA BETA-GLUCAN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 173. SPAIN BETA-GLUCAN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 174. SPAIN BETA-GLUCAN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 175. SPAIN BETA-GLUCAN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 176. SPAIN BETA-GLUCAN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 177. SWEDEN BETA-GLUCAN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 178. SWEDEN BETA-GLUCAN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 179. SWEDEN BETA-GLUCAN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 180. SWEDEN BETA-GLUCAN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 181. SWITZERLAND BETA-GLUCAN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 182. SWITZERLAND BETA-GLUCAN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 183. SWITZERLAND BETA-GLUCAN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 184. SWITZERLAND BETA-GLUCAN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 185. TURKEY BETA-GLUCAN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 186. TURKEY BETA-GLUCAN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 187. TURKEY BETA-GLUCAN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 188. TURKEY BETA-GLUCAN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 189. UNITED ARAB EMIRATES BETA-GLUCAN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 190. UNITED ARAB EMIRATES BETA-GLUCAN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 191. UNITED ARAB EMIRATES BETA-GLUCAN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 192. UNITED ARAB EMIRATES BETA-GLUCAN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 193. UNITED KINGDOM BETA-GLUCAN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 194. UNITED KINGDOM BETA-GLUCAN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 195. UNITED KINGDOM BETA-GLUCAN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 196. UNITED KINGDOM BETA-GLUCAN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 197. BETA-GLUCAN MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 198. BETA-GLUCAN MARKET, FPNV POSITIONING MATRIX, 2023

The Beta-Glucan Market was valued at USD 571.01 million in 2023, expected to reach USD 616.75 million in 2024, and is projected to grow at a CAGR of 8.18%, to USD 990.45 million by 2030.

Beta-glucan, a naturally occurring polysaccharide found in the cell walls of cereals, bacteria, and fungi, is recognized for its significant health benefits and applications across various industries. The necessity for beta-glucan stems from its immune-enhancing and cholesterol-lowering properties, making it vital in dietary supplements, pharmaceuticals, and functional food products. Additionally, its application extends to cosmetics for its skin-soothing qualities. The end-use scope is broad, encompassing sectors such as health and wellness, pharmaceuticals, food and beverages, and personal care. Market growth is influenced by rising consumer awareness of health and wellness, increasing prevalence of lifestyle-related diseases, and the demand for natural and organic ingredients. However, the market faces challenges such as high production costs, lack of consumer awareness in certain regions, and stringent regulatory approvals, particularly in developing markets. Nonetheless, the increasing trend towards preventive healthcare and rising research and development activities present potential opportunities. Innovations in extraction and processing techniques can lower production costs, enhance product efficacy, and expand applications, thus offering lucrative opportunities for market players. Companies should focus on strategic partnerships, technological advancements, and product diversification to leverage the burgeoning market. Engaging in awareness campaigns could also help combat the knowledge gap among consumers. While the beta-glucan market is set on a growth trajectory due to its diverse applicability and health benefits, the competitive landscape demands constant innovation and strategic positioning. Furthermore, investing in sustainable practices and tapping into the underexplored Asian market could be pivotal for long-term growth. By focusing on these areas, businesses can navigate the market's limitations and capitalize on its expansion potential, thereby ensuring sustainable growth and market relevance.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Beta-Glucan Market

The Beta-Glucan Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Growing awareness among consumers regarding the health benefits of beta-glucan
  • Increasing demand for nutraceuticals and functional foods
• Market Restraints
  • Fluctuating prices of raw materials associated with the production of beta-glucan
• Market Opportunities
  • Increasing research & development for the development of new sources, and delivery systems for beta-glucan
  • High potential in animal feed and veterinary applications
• Market Challenges
  • Certain issues in the formulation and stability of beta-glucan

Porter's Five Forces: A Strategic Tool for Navigating the Beta-Glucan Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Beta-Glucan Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Beta-Glucan Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Beta-Glucan Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Beta-Glucan Market

A detailed market share analysis in the Beta-Glucan Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Beta-Glucan Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Beta-Glucan Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Beta-Glucan Market

A strategic analysis of the Beta-Glucan Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Beta-Glucan Market, highlighting leading vendors and their innovative profiles. These include ABF Ingredients Group, Alltech Life Sciences, Angel Yeast Co., Ltd., Associated British Foods PLC, Auriga Group, Biopolymer Engineering Inc., Biorigin, Biotec Pharmacon ASA, Cargill, Inc., Ceapro Inc., DSM Nutritional Products AG, Euglena Co. Ltd, Garuda International, Inc., Givaudan SA, GlycaNova AS, Kemin Industries Inc., Kerry Group PLC, Merck KGaA, NutraQ AS, NutriScience Innovations, LLC, and Super Beta Glucan Inc..

Market Segmentation & Coverage

This research report categorizes the Beta-Glucan Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Avenacare, Glucagel, Nutrim, Oatwell, Promoat, Sanacel, Wellmune, and Yestimun.
• Based on Type, market is studied across Insoluble Beta-Glucan and Soluble Beta-Glucan.
• Based on Source, market is studied across Cereal, Mushroom, Seaweed, and Yeast.
• Based on Application, market is studied across Animal Feed, Cosmetics & Personal Care, Food & Beverage, and Medical & Pharmaceuticals.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing awareness among consumers regarding the health benefits of beta-glucan
    • 5.1.1.2. Increasing demand for nutraceuticals and functional foods
  • 5.1.2. Restraints
    • 5.1.2.1. Fluctuating prices of raw materials associated with the production of beta-glucan
  • 5.1.3. Opportunities
    • 5.1.3.1. Increasing research & development for the development of new sources, and delivery systems for beta-glucan
    • 5.1.3.2. High potential in animal feed and veterinary applications
  • 5.1.4. Challenges
    • 5.1.4.1. Certain issues in the formulation and stability of beta-glucan
• 5.2. Market Segmentation Analysis
  • 5.2.1. Product: Growing usage of avenacare in personal care and cosmetics due to its skin-soothing properties
  • 5.2.2. Application: High potential of beta-glucan in animal feed to reduce the use of antibiotics and promote sustainable animal health practices
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Beta-Glucan Market, by Product

• 6.1. Introduction
• 6.2. Avenacare
• 6.3. Glucagel
• 6.4. Nutrim
• 6.5. Oatwell
• 6.6. Promoat
• 6.7. Sanacel
• 6.8. Wellmune
• 6.9. Yestimun

7. Beta-Glucan Market, by Type

• 7.1. Introduction
• 7.2. Insoluble Beta-Glucan
• 7.3. Soluble Beta-Glucan

8. Beta-Glucan Market, by Source

• 8.1. Introduction
• 8.2. Cereal
• 8.3. Mushroom
• 8.4. Seaweed
• 8.5. Yeast

9. Beta-Glucan Market, by Application

• 9.1. Introduction
• 9.2. Animal Feed
• 9.3. Cosmetics & Personal Care
• 9.4. Food & Beverage
• 9.5. Medical & Pharmaceuticals

10. Americas Beta-Glucan Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Beta-Glucan Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Beta-Glucan Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
  • 13.3.1. Launch of BENEO's Orafti B-Fit at the IFT Food Expo: Introducing Heart-Healthy Barley Beta-Glucans
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. ABF Ingredients Group
• 2. Alltech Life Sciences
• 3. Angel Yeast Co., Ltd.
• 4. Associated British Foods PLC
• 5. Auriga Group
• 6. Biopolymer Engineering Inc.
• 7. Biorigin
• 8. Biotec Pharmacon ASA
• 9. Cargill, Inc.
• 10. Ceapro Inc.
• 11. DSM Nutritional Products AG
• 12. Euglena Co. Ltd
• 13. Garuda International, Inc.
• 14. Givaudan SA
• 15. GlycaNova AS
• 16. Kemin Industries Inc.
• 17. Kerry Group PLC
• 18. Merck KGaA
• 19. NutraQ AS
• 20. NutriScience Innovations, LLC
• 21. Super Beta Glucan Inc.